Notation to File

NOTE TO THE FILE

SERIAL NUMBER:            88414984

DATE:                                11/18/2019

NAME:                               jsjogren

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
        phone                               Left message with
    X   email                               Attorney/Applicant

     Requested Law Library search       X   Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

     OTHER:

From: Douglas Wolf <Doug.Wolf@wolfgreenfield.com>
Sent: Wednesday, November 13, 2019 1:49 PM
To: Sjogren, Jeffrey <Jeffrey.Sjogren@USPTO.GOV>
Subject: RE: OFFICIAL USPTO EMAIL--Serial No. 88414984--Examiner's Amendment - Response Required

 

Jeff

 

Thanks for the call.  Please fill in that language as follows:

 

pharmaceutical products for the prevention and treatment of cancer, tumors, autoimmune disorders, neurological, vascular and infectious diseases; pharmaceutical preparations for immunotherapy.

 

Best,

 

Doug

Douglas R. Wolf | Chair, Trademark Group Doug.Wolf@wolfgreenfield.com   617.646.8260 | cell 617.851.1377 | fax 617.646.8646

Wolf, Greenfield & Sacks, P.C. 600 Atlantic Avenue | Boston, MA 02210 405 Lexington Avenue | New York, NY 10174 http://www.wolfgreenfield.com |

 

From: Sjogren, Jeffrey [mailto:Jeffrey.Sjogren@USPTO.GOV]
Sent: Wednesday, November 13, 2019 12:24 PM
To: Wolf, Douglas R. <Doug.Wolf@wolfgreenfield.com>
Subject: OFFICIAL USPTO EMAIL--Serial No. 88414984--Examiner's Amendment - Response Required

 

Hi Mr. Wolf,

 

We just spoke on the phone regarding trademark application Serial No. 88414984.  You said your client provided you with a list of conditions to add to the identification.  Here is a template for your use to fill in those conditions:

 

CLASS 005:           pharmaceutical products for the prevention and treatment of cancer, tumors, {specify the diseases and disorders}; pharmaceutical preparations for immunotherapy

 

Once I receive your additions, I will issue an Examiner’s Amendment and, barring disagreement from my supervisor, conduct my final review before approving the mark for publication.  Talk with you soon.

 

Best,

 

Jeff

 

Jeffrey Sjogren

Examining Attorney—Law Office 122

United States Patent and Trademark Office

Jeffrey.Sjogren@USPTO.gov

Phone: 571-272-5279

Fax: 571-273-5578

 

Please be aware that all relevant email communications will be placed in the official application record.  Although the trademark examining attorney may provide additional explanation pertaining to the application, the trademark examining attorney may not provide legal advice or statements about applicant’s rights.  See TMEP §§705.02, 709.06.